First Time Loading...

Takara Bio Inc
TSE:4974

Watchlist Manager
Takara Bio Inc Logo
Takara Bio Inc
TSE:4974
Watchlist
Price: 1 010 JPY -0.49% Market Closed
Updated: May 4, 2024
Section:
 

Relative Value

The Relative Value of one Takara Bio Inc stock under the Base Case scenario is 1 210.1 JPY. Compared to the current market price of 1 010 JPY, Takara Bio Inc is Undervalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
1 210.1 JPY
Undervaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.6
P/S
P/S
Price to Sales
2.6
vs History
84
vs Industry
77
Median 3Y
3.1
Median 5Y
5.7
Industry
8.1
Forward
2.5
More Details
77.4
P/E
P/E
Price to Earnings
77.4
vs History
17
vs Industry
2
Median 3Y
16.8
Median 5Y
35.2
Industry
26.2
Forward
64.7
More Details
5
P/OCF
P/OCF
Price to OCF
5
vs History
93
vs Industry
13
Median 3Y
18.9
Median 5Y
35
Industry
22.6
More Details
12.6
P/FCFE
P/FCFE
Price to FCFE
12.6
vs History
47
vs Industry
9
Median 3Y
10
Median 5Y
12.5
Industry
21.3
More Details
1.1
P/B
P/B
Price to Book Value
1.1
vs History
95
vs Industry
61
Median 3Y
2
Median 5Y
3.6
Industry
2.5
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
92
vs Industry
71
Median 3Y
2.6
Median 5Y
5.2
Industry
7.3
Forward
1.8
More Details
3.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.3
vs History
92
vs Industry
64
Median 3Y
4
Median 5Y
7.1
Industry
9.1
More Details
13.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.4
vs History
47
vs Industry
8
Median 3Y
7.9
Median 5Y
13.3
Industry
4.4
Forward
11.1
More Details
58.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
58.5
vs History
9
vs Industry
2
Median 3Y
9.6
Median 5Y
22.3
Industry
4.3
More Details
3.6
EV/OCF
EV/OCF
Enterprise Value to OCF
3.6
vs History
93
vs Industry
13
Median 3Y
17.1
Median 5Y
31
Industry
5.4
More Details
8.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
8.8
vs History
47
vs Industry
9
Median 3Y
7.5
Median 5Y
8.6
Industry
3.2
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
95
vs Industry
60
Median 3Y
2.1
Median 5Y
3.9
Industry
5
More Details

Multiples Across Competitors

Competitors Multiples
Takara Bio Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Takara Bio Inc
TSE:4974
121.6B JPY 2.6 77.4 13.4 58.5
US
Abbvie Inc
NYSE:ABBV
287.1B USD 5.3 60 12.9 19.7
US
Amgen Inc
NASDAQ:AMGN
168.4B USD 6 25.1 18 27
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
103.5B USD 7.9 26.2 17.6 19.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.4B USD 10.5 28.6 22.8 23.9
AU
CSL Ltd
ASX:CSL
133.2B AUD 6.2 35.6 21.6 26.7
US
Gilead Sciences Inc
NASDAQ:GILD
80.3B USD 2.9 166 6.7 8.7
US
Moderna Inc
NASDAQ:MRNA
46.9B USD 6.9 -10 -10.8 -9.2
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.5B USD 3.3 27 13.8 17.3
KR
Celltrion Inc
KRX:068270
39.2T KRW 18 73.1 44.7 61.6

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.